ATHA

Athira Pharma, Inc. is a late-stage biopharmaceutical company based in Bothell, Washington, that specializes in developing innovative therapies to restore neuronal health and address neurodegeneration. The company is advancing a robust pipeline of small molecule candidates targeting the underlying mechanisms of neurodegenerative diseases, with a primary focus on Alzheimer's disease. Through its dedication to addressing critical unmet medical needs, Athira Pharma aims to significantly enhance the quality of life for patients affected by these challenging conditions, positioning itself as a key player in the neurology sector.